Clinical Trials Browser

NIH × Interventional × amrubicin × Clear all

NCT00132054 2013-05-30

Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer

Phase 1 Completed

Lung Neoplasms, Small Cell Lung Carcinoma